top of page

The Importance of Optimized Medication Therapy

Non-optimized medication therapy is a major issue in healthcare, leading to significant costs and adverse health outcomes. Research indicates that the annual cost of illness and death resulting from non-optimized medication therapy is estimated to be $528.4 billion, representing about 16% of total U.S. healthcare expenditures in 2016. These costs arise from various factors, including emergency department visits, hospitalizations, long-term care, and additional medical appointments and medications (Pharmacy Times, Annals of Pharmacotherapy).


End-to-End Solution

Optimizing medication regimens through risk assessment,  communication and comprehensive medication management programs can significantly reduce these costs and improve patient outcomes. A system like Cygenex's "End-to-End Solution"  can oversee this crucial role in ensuring that medication therapies are correctly optimized to produce the best outcomes at the lowest cost.


For more detailed Insights of our End-to-End Solutions


Choose introduction to Cygenex

bottom of page